Back to Top Skip to main content Skip to sub-navigation

DOD Officials Announce Distribution Plan for Initial COVID-19 Vaccine

Image of Mr. McCaffery speaking at a podium at the Pentagon Thomas McCaffery, the assistant secretary of defense for health affairs, briefs reporters at the Pentagon on the department’s phase, standardized and coordinated strategy for distributing and administrating COVID-19 vaccines, Dec 9, 2020. (DOD photo by Air Force Staff Sgt. Brittany Chase.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Regarding the initial COVID-19 vaccination rollout, Defense Department officials announced a phased and coordinated strategic plan for distributing and administering the initial COVID-19 vaccines.

Chief Pentagon spokesman, Jonathan Rath Hoffman; Assistant Secretary of Defense for Health Affairs Thomas McCaffery; and, Army Lt. Gen. Ronald J. Place, director, Defense Health Agency, described the plan at a press briefing in the Pentagon today.

"In the coming days we expect the department to receive its first allotment of the vaccine," McCaffery said, noting that DOD is expected to receive around 44,000 doses of the Pfizer vaccine in the initial phase, as early as next week, for immediate use.

An additional 44,000 doses would then be required for the follow-up dose in the two-shot series. 

Per the Centers of Disease Control and Prevention guidance, DOD will administer the first batch to health care providers and then in DOD long-term care facilities, to high-risk populations, those in critical national capability positions and finally, healthy populations, McCaffery said. 

That first batch of vaccines will be distributed to 16 locations, including three overseas. That delivery McCaffery termed a "control pilot."

The 16 sites were selected based on a sizable DOD population of high priority personnel, cold storage capability and sufficient medical personnel to administer the vaccines and monitor recipients after receiving them, he said.

As soon as the Food and Drug Administration issues an emergency use authorization, or EUA, the DOD's allocation will be pre-positioned at those 16 sites. After issuance of the EUA, the CDC's Advisory Committee on Immunization Practices, or ACIP, will meet to review the EUA, The ACIP will then vote to recommend a vaccine, how it should be disseminated and who should receive it first, and then the order of the follow-on recipients.

"We expect to have shots in arms of DOD personnel within 20 to 48 hours from the time the ACIP issues its final recommendation," McCaffery added.

As lessons from the control pilot are learned, and more vaccines are made available over time, additional locations will be added, and additional personnel, besides health care providers, will be added, he said. Eventually, all department personnel will be eligible to be vaccinated: active and selective reserve components, including the National Guard, family members, retirees, DOD civilians and select DOD contractors.

"Future allocations of the COVID-19 vaccine will focus on vaccinating priority populations quickly and safely, while simultaneously refining the intricate planning for the delivery of larger volumes of vaccine in future waves," McCaffery said.

The department will prioritize DOD personnel to receive the vaccine based on the CDC guidance and on the department's COVID Task Force assessment of unique mission requirements, he said.

"The department's priorities are protecting our service members, our civilian employees and families and safeguarding our national security capabilities in supporting the whole of government response to the COVID-19 pandemic," said McCaffery. 

The department's plan to distribute the vaccine DOD-wide was developed in collaboration with Operation Warp Speed and CDC guidance, he said.

Place encouraged DOD personnel to take the vaccine when it becomes available, because as for now, it is voluntary.

"While we await final approval from the FDA, the preliminary data on the safety and effectiveness of the two vaccine candidates is highly encouraging and we're recommending that everyone take the vaccine when it becomes available to protect yourselves, your families, your shipmates, your wingman your battle buddies and your communities," Place said. 

The other vaccine he spoke of is made by Moderna and is expected to be made available to the department in the near future.

"As with most vaccines, some people may experience small adverse effects such as arm soreness, fatigue, even a fever," Place said. "The department will be fully transparent about any adverse effects that are reported and will share this information with the CDC."

Hoffman added his agreement with Place: "Our goal is to be transparent with the force about what is happening, and to encourage our personnel to use the vaccine."

You also may be interested in...

COVID-19 Vaccine Approved for Adolescents Ages 12 and Over

Publication
5/13/2021

The Pfizer-BioNTech vaccine is approved for those ages 12 and over. Includes a photo of adolescents at the top of the page, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

Line Leader Presentation (PDF)

Publication
5/7/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Reasons to Choose a COVID-19 Vaccine Fact Sheet

Publication
5/7/2021

Leaders and public affairs officers can share this information across channels to continue the vaccine confidence conversation.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Line Leader Presentation PPT

Publication
5/7/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Presentation Companion

Publication
5/7/2021

Leaders and public affairs officers may reference this document. It can be shared with commands to support briefings, or distributed independently to share facts about COVID-19 vaccines.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

VAX Facts about Breastfeeding

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

VAX Facts How Long does Protection Last?

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

VAX Facts about Having COVID-19

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

VAX Facts about Pregnancy

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

VAX Facts Underlying Conditions

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

VAX Facts about Fertility

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

COVID Vaccine Printable Pharmacy Insert

Publication
4/2/2021

An insert with links to learn more about vaccination options. Options include MTFs, state health departments, and local retail pharmacy. Graphics include medical personnel wearing masks on the bottom as well as the TRICARE logo.

Recommended Content:

COVID-19 Vaccine Toolkit

Template: COVID-19 Vaccine Key Messages

Publication
3/17/2021

These are a list of important messages about the COVID-19 vaccine that you should share with your constituents.

Recommended Content:

COVID-19 Vaccine Toolkit

Getting the COVID-19 Vaccine at Civilian Pharmacies

Publication
3/9/2021

YOU CAN GET THE COVID-19 VACCINE FROM ANY CIVILIAN PHARMACY AT NO CHARGE, EVEN NON-NETWORK PHARMACIES, BUT HERE ARE SOME THINGS TO KEEP IN MIND.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus

Access to COVID-19 Vaccine for Members of the Selected Reserve (SELRES)

Publication
3/2/2021

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus
<< < 1 2 3 4 > >> 
Showing results 1 - 15 Page 1 of 4

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.